Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.
Nov 2011 - J Transl Med; 9:1479-5876 [PMID:22013914]
[Baek S] [Kim CS] [Kim SB] [Kim YM] [Kwon SW] [Kim Y] [Kim H] [Lee H]

Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL.
Sep 2009 - Mol. Ther.:1525-0024 [PMID:19738604]
[Huang JH] [Zhang SN] [Choi KJ] [Choi IK] [Kim JH] [Lee M] [Kim H] [Yun CO]